MOGCTs can lead to elevations of tumor markers in the peripheral blood, including alpha-fetoprotein (AFP), beta-human chorionic gonadotropin (hCG) and lactate dehydrogenase (LDH) [7,38,39]. This evidence concerns the gene AFP and neoplasm.